Provided by Tiger Fintech (Singapore) Pte. Ltd.

SITC

18.620
+0.1000.54%
Volume:7.76M
Turnover:143.10M
Market Cap:50.03B
PE:11.94
High:18.660
Open:18.340
Low:18.140
Close:18.520
Loading ...

Private companies invested in SITC International Holdings Company Limited (HKG:1308) copped the brunt of last week's HK$2.6b market cap decline

Simply Wall St.
·
24 Feb

SITC International Holdings Company Limited's (HKG:1308) Price Is Out Of Tune With Earnings

Simply Wall St.
·
09 Feb

SITC International Unit Exercises Option to Get Two Container Vessels Built

MT Newswires Live
·
24 Jan

SITC International - SITC Shipowning Exercised Options for Construction of 2 Additional Container Vessels for US$57.96 Mln

THOMSON REUTERS
·
24 Jan

SITC International Expects Up to 92% Increase in 2024 Profit

MT Newswires Live
·
21 Jan

BRIEF-SITC International Sees FY Unaudited Profit Attributable Between $1,000.0 Mln & $1,030.0 Mln

Reuters
·
20 Jan

SITC International - Expected Result Due to Increase in Group's Container Shipping Volume, Others

THOMSON REUTERS
·
20 Jan

SITC International Sees Unaudited Profit Attributable for Year Between $1,000.0 Mln & US$1,030.0 Mln

THOMSON REUTERS
·
20 Jan

SITC International Holdings' (HKG:1308) five-year total shareholder returns outpace the underlying earnings growth

Simply Wall St.
·
09 Jan

SITC International Holdings (HKG:1308) Seems To Use Debt Quite Sensibly

Simply Wall St.
·
24 Dec 2024

At HK$21.20, Is It Time To Put SITC International Holdings Company Limited (HKG:1308) On Your Watch List?

Simply Wall St.
·
10 Dec 2024

Why We Like The Returns At SITC International Holdings (HKG:1308)

Simply Wall St.
·
25 Nov 2024

HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker

GlobeNewswire
·
12 Nov 2024

Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire
·
11 Nov 2024

While individual investors own 26% of SITC International Holdings Company Limited (HKG:1308), private companies are its largest shareholders with 41% ownership

Simply Wall St.
·
11 Nov 2024

Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting

GlobeNewswire
·
09 Nov 2024